Protara Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: TARA · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1359931
| Field | Detail |
|---|---|
| Company | Protara Therapeutics, Inc. (TARA) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: TARA
TL;DR
Protara (TARA) filed an 8-K for shareholder vote matters. Keep an eye on the outcome.
AI Summary
Protara Therapeutics, Inc. filed an 8-K on June 12, 2025, reporting on matters submitted to a vote of its security holders as of June 11, 2025. The filing indicates a change in the company's reporting status or a significant corporate event requiring shareholder approval. The company, formerly known as ArTara Therapeutics, Inc. and Proteon Therapeutics Inc., is based in New York, NY.
Why It Matters
This filing signals a significant corporate action or decision requiring shareholder approval, which could impact the company's future direction and stock value.
Risk Assessment
Risk Level: medium — Filings related to shareholder votes often precede significant corporate changes that can introduce volatility.
Key Players & Entities
- Protara Therapeutics, Inc. (company) — Registrant
- June 11, 2025 (date) — Earliest event reported
- June 12, 2025 (date) — Date of report
- ArTara Therapeutics, Inc. (company) — Former company name
- Proteon Therapeutics Inc (company) — Former company name
- 345 Park Avenue South, Third Floor, New York, NY 10010 (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Protara Therapeutics, Inc. security holders?
The filing does not specify the exact matters submitted for a vote, only that such matters were reported on as of June 11, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 11, 2025.
What is the IRS Employer Identification Number for Protara Therapeutics, Inc.?
The IRS Employer Identification Number for Protara Therapeutics, Inc. is 20-4580525.
What were Protara Therapeutics, Inc.'s former company names?
Protara Therapeutics, Inc. was formerly known as ArTara Therapeutics, Inc. and Proteon Therapeutics Inc.
Where are Protara Therapeutics, Inc.'s principal executive offices located?
Protara Therapeutics, Inc.'s principal executive offices are located at 345 Park Avenue South, Third Floor, New York, NY 10010.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Protara Therapeutics, Inc. (TARA).